Sanofi: dedicated cycle of interactive webcasts

(CercleFinance.com) - Sanofi has announced that it is organising an interactive webcast cycle to highlight the main pipeline programs of its development portfolio, which will culminate in a virtual R&D day event on Thursday 23 June.


This five-webcast cycle was inaugurated in April, with the presentation of phase II data and its development strategy on its brain-penetrant BTKi'168 inhibitor in the treatment of multiple sclerosis.

The forthcoming sessions will present the group's strategy in oncology, its plans to extend the Dupixent range, and nirsevimab, the first time a monoclonal antibody potentially offers a population-based solution to prevent respiratory syncytial virus (RSV) for all infants.


Copyright (c) 2020 CercleFinance.com. All rights reserved.